Intra-vascular glucocorticoid metabolism as a modulator of vascular structure and function |
| |
Authors: | P. W. F. Hadoke L. Macdonald J. J. Logie G. R. Small A. R. Dover B. R. Walker |
| |
Affiliation: | (1) Endocrinology Unit, Centre for Cardiovascular Science, Edinburgh University, The Queen’s Medical Research Institute, 47, Little France Crescent, Edinburgh, EH16 4TJ, Scotland (United Kingdom) |
| |
Abstract: | ![]() The ability of glucocorticoids to directly alter arterial function, structure and the inflammatory response to vascular injury may contribute to their well-established link with the development of cardiovascular disease. Recent studies have emphasised the importance of tissue-specific regulation of glucocorticoid availability by the 11 β-hydroxysteroid dehydrogenase (11HSD) isozymes, which inter-convert active glucocorticoids and their inactive metabolites. The expression of both type 1 and type 2 11HSDs in the arterial wall suggests that prereceptor metabolism of glucocorticoids may have a direct impact on vascular physiology. Indeed there is evidence that 11HSDs influence glucocorticoid-mediated changes in vascular contractility, vascular structure, the inflammatory response to injury and the growth of new blood vessels. Hence, inhibition of 11HSD isozymes may provide a novel therapeutic target in vascular disease. Received 19 September 2005; received after revision 1 November 2005; accepted 25 November 2005 |
| |
Keywords: | 11β -Hydroxysteroid dehydrogenase inflammation vascular contractility angiogenesis cardiovascular disease |
本文献已被 PubMed SpringerLink 等数据库收录! |
|